{
    "Trade/Device Name(s)": [
        "URiSCAN 2ACR Urine strips",
        "URiSCAN Optima Urine analyzer"
    ],
    "Submitter Information": "YD Diagnostics Corp.",
    "510(k) Number": "K141874",
    "Predicate Device Reference 510(k) Number(s)": [
        "K091216"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JFY",
        "JIR",
        "KQO"
    ],
    "Summary Letter Date": "April 8, 2015",
    "Summary Letter Received Date": "April 15, 2015",
    "Submission Date": "Feb 05, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1225"
    ],
    "Regulation Name(s)": [
        "Creatinine test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Albumin",
        "Creatinine",
        "Albumin Creatinine Ratio (ACR)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Clean, dry container"
    ],
    "Instrument(s)/Platform(s)": [
        "URiSCAN Optima Urine analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Colorimetric urine test strip analysis"
    ],
    "Methodologies": [
        "Semi-quantitative colorimetric detection"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Strip",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for URiSCAN Optima urine analyzer and 2ACR urine strips for semi-quantitative measurement of albumin, creatinine, and ACR in urine",
    "Indications for Use Summary": "Intended for in vitro semi-quantitative measurement of albumin, creatinine, and ACR in urine to aid in evaluating renal, urinary, and metabolic disorders, for prescription use in clinical laboratory and point-of-care settings",
    "fda_folder": "Clinical Chemistry"
}